Spots Global Cancer Trial Database for A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer
Official Title: A Randomized, Positive Parallel Controlled, Multicenter Phase III Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer
Study ID: NCT04523272
Conditions
Study Description
Brief Summary: This study is a randomized, positive parallel controlled, multicentre phase III clinical trial to evaluate the efficacy and safety of TQB2450 combined with anlotinib versus sunitinib in subjects with advanced renal cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
China-Japan Friendship Hospital, Beijing, Beijing, China
Peking Union Medical College Hospital, Beijing, Beijing, China
Peking University First Hospital, Beijing, Beijing, China
Beijing Cancer Hospital, Beijing, Beijing, China
Peking University Third Hospital, Beijing, Beijing, China
Chinese PLA General Hospital, Beijing, Beijing, China
Chongqing University Cancer Hospital, Chongqing, Chongqing, China
Fujian Provincial Hospital, Fuzhou, Fujian, China
Sun Yat-sen of Cancer Center, Guangzhou, Guangdong, China
The Affiliated Tumor Hospital of Harbin Medical University, Harbin, Heilongjiang, China
Hunan Cancer Hospital, Changsha, Hunan, China
The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China
Jiangxi Cancer Hospital, Nanchang, Jiangxi, China
The First Hospital of Jilin University, Changchun, Jilin, China
The Second Hospital of Dalian Medical University, Dalian, Liaoning, China
Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China
Qilu Hospital of Shandong University, Jinan, Shandong, China
Tenth People's Hospital of Tongji University, Shanghai, Shanghai, China
The First Affiliated Hospital of PLA Air Force Military Medical University, Xi'an, Shanxi, China
West China Hospital of Sichuan University, Chengdu, Sichuan, China
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin, China
First Affiliated Hospital,School of Medicine,Shihezi University, Shihezi, Xinjiang, China
The Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China
Cancer Hospital of The University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
